This is a study to assess if men with metastatic prostate cancer who are undergoing androgen deprivation treatments respond to the experimental med dasatinib. Bone-loss markers will be assessed during the trial. This international study is currently recruiting patients.
Read moreYou're concerned about your bone health. Perhaps you've heard the worrisome statistics - that up to half of postmenopausal women, and a... Read more »
Recently, we heard about Gwyneth Paltrows' diagnosis of osteopenia; this news put another spotlight on the benefits of early detection for... Read more »
This article is a follow-up to the last titled Secondary Causes of Osteoporosis: Could They be Causing Your Low T-Scores? In this post... Read more »
Wouldn't it be fantastic if we could slow or even stop the progression of osteoporosis? Well the Best Bones ForeverTM web site, under the... Read more »
That is essentially the question investigated in the Aug. 8 issue of JAMA, which evaluates whether it is cost-effective for men to receive... Read more »
Loop diuretics, which are used to treat heart failure and high blood pressure, have been linked to increased hip bone loss in older men. Connecticut... Read more »
Source: Breastcancer.org
Your bones give your body its shape, help you move, and support your body. Your bones also help protect your heart, lungs, and brain. Even though... Read more »
Source: eOrthopod
Osteolysis or bone loss after total knee replacement (TKR) can be a problem. Tiny flecks of bone and debris from the backside of the implant lead to... Read more »
Men with prostate cancer who take the osteoporosis med Fosamax may reduce their risk of chemotherapy-related bone loss, a small study has found.... Read more »
(Ivanhoe Newswire) -- Loop diuretics -- commonly prescribed drugs for heart failure and hypertension -- may cause hip bone loss in men, a new study... Read more »